Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 1976 | Published
Journal Article Open

A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus

Abstract

A quantitative Abelson murine leukemia virus (A-MuLV) lymphoid cell transformation assay has been developed using a semisolid agarose culture system. Under these conditions lymphoid cell transformation was shown to vary linearly with the dose of A-MuLV used. The susceptibility of bone marrow cells from different strains of mice to A-MuLV-induced transformation can be estimated using the agarose assay. Strains with bone marrow cells of high, medium, and low susceptibility to A-MuLV can be identified. The assay has been used to study the susceptibility of cells from lymphoid organs of fetal and adult mice to A-MuLV. Cell suspensions from fetal liver, adult bone marrow, and adult spleen are susceptible to A-MuLV, while thymocytes are resistant to A-MuLV-induced transformation. Bovine serum albumin gradient fractionation of bone marrow cells before infection with A-MuLV demonstrates that the majority of A-MuLV-sensitive cells are recovered in a broad band partially overlapping the majority of the nucleated cells. The agarose assay system allows study of A-MuLV-lymphoid cell interaction at the level of single cell-single virus particle interaction.

Additional Information

© 1976 by Rockefeller University Press. RUP grants the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode. Received for publication 9 February 1976. We are grateful to Dr. P.C. Kung for his advice on the use of bovine serum albumin gradients. Supported by grant no. VC-4G from the American Cancer Society, a contract from the Virus Cancer Program, and a grant no. CA-14051 from the National Cancer Institute. [N.R. was a] Postdoctoral fellow of the Massachusetts Division of the American Cancer Society. [D.B. was an] American Cancer Society Professor of Microbiology.

Attached Files

Published - ROSjem76.pdf

Files

ROSjem76.pdf
Files (1.4 MB)
Name Size Download all
md5:19ab2c7250d244750bd2032d9217faed
1.4 MB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 16, 2023